Exchange: NASDAQ Capital Market Sector: Healthcare Industry: Diagnostics & Research
-0.15% $6.80
Last updated: 8 aug 2022 - 0:11
TimeZone: America/New_York
FUNDAMENTALS | |
---|---|
MarketCap: | 229.71 mill |
EPS: | 1.360 |
P/E: | 5.00 |
Earnings Date: | Aug 11, 2022 |
SharesOutstanding: | 33.78 mill |
Avg Daily Volume: | 0.538 mill |
RATING 2022-08-05 |
---|
A |
Buy |
RATINGDETAILS | ||
---|---|---|
Rating CashFlow: | Strong Buy | |
Return On Equity: | Neutral | |
Return On Asset: | Neutral | |
DE: | Neutral | |
P/E: | Buy | |
Price To Book: | Strong Buy |
QUARTER GROWTHS | ||||||
---|---|---|---|---|---|---|
4/20 | 1/21 | 2/21 | 3/21 | 4/21 | 1/22 | |
Revenue | ||||||
Gr.Profit | ||||||
Ebit | ||||||
Asset | ||||||
Debt | n/a | n/a | n/a | n/a | n/a | n/a |
PE RATIO: COMPANY / SECTOR |
---|
0.06x |
Company: PE 5.00 | sector: PE 82.90 |
PE RATIO: COMPANY / INDUSTRY |
---|
infx |
Company: PE 5.00 | industry: PE 0.000 |
DISCOUNTED CASH FLOW VALUE |
---|
$9.76 (43.57%) $2.96 |
Date: 2022-08-08 |
Expected Trading Range (DAY) |
---|
$ 6.40 - 7.20 ( +/- 5.85%) |
ATR Model: 14 days |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2022-07-11 | Serbin Richard S | Buy | 70 000 | Restricted Stock Units |
2022-07-11 | Nelson James B | Buy | 70 000 | Restricted Stock Units |
2022-07-11 | Murphy Ted | Buy | 70 000 | Restricted Stock Units |
2022-07-11 | Durenard Eugene | Buy | 70 000 | Restricted Stock Units |
2022-06-06 | Egan Dwight H | Buy | 275 000 | Restricted Stock Units |
INSIDER POWER |
---|
49.60 |
Last 100 transactions |
Buy: 2 356 918 | Sell: 1 269 849 |
Indicator Signals | |
---|---|
RSI 21 | |
SMA | |
Trend | |
Trend 2 | |
Trend 3 | |
MACD |
Volume Signals | |
---|---|
Price | $6.80 (-0.15% ) |
Volume | 0.532 mill |
Avg. Vol. | 0.538 mill |
% of Avg. Vol | 98.88 % |
Signal 1: | |
Signal 2: |
123 Signals | Accuracy: 19.51% | Accuracy Buy: 19.35% | Accuracy Sell: 19.67%
Avg return buy: -0.14 % | Avg return sell: 0.36 %
$1 invested is now $0.91 or -8.84% since 25-07-22
Date | Signal | @ | Closed | % | Aug 5 - 15:34 | sell | $6.85 | N/A | Active |
---|---|---|---|---|
Aug 5 - 14:58 | buy | $6.86 | $6.85 @ Aug 5 - 15:34 | -0.15% |
Aug 5 - 14:51 | sell | $6.86 | $6.86 @ Aug 5 - 14:58 | 0.07% |
Aug 5 - 14:45 | buy | $6.86 | $6.86 @ Aug 5 - 14:51 | -0.07% |
Aug 5 - 14:43 | sell | $6.86 | $6.86 @ Aug 5 - 14:45 | 0.07% |
Aug 5 - 14:38 | buy | $6.87 | $6.86 @ Aug 5 - 14:43 | -0.22% |
Aug 5 - 13:52 | sell | $6.87 | $6.87 @ Aug 5 - 14:38 | 0.00% |
Aug 5 - 12:47 | buy | $6.85 | $6.87 @ Aug 5 - 13:52 | 0.24% |
Aug 5 - 12:43 | sell | $6.82 | $6.85 @ Aug 5 - 12:47 | 0.49% |
Aug 5 - 12:00 | buy | $6.81 | $6.82 @ Aug 5 - 12:43 | 0.15% |
Co-Diagnostics, Inc., a molecular diagnostics company, intends to manufacture and sell reagents used for diagnostic tests that function via the detection and/or analysis of nucleic acid molecules. It also intends to sell diagnostic equipment from other manufacturers as self-contained lab systems. The company was founded in 2013 and is headquartered in Salt Lake City, Utah.